Imidazole(CAS 288-32-4)
Imidazole(CAS 288-32-4) market is segmented by region (country), players, by Type and by Applicat ... Read More
Global and United States Human Hepatitis B Immunoglobulin(HBIG) Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Human Hepatitis B Immunoglobulin(HBIG) Product Introduction
1.2 Global Human Hepatitis B Immunoglobulin(HBIG) Outlook 2017 VS 2022 VS 2028
1.2.1 Global Human Hepatitis B Immunoglobulin(HBIG) Sales in US$ Million for the Year 2017-2028
1.2.2 Global Human Hepatitis B Immunoglobulin(HBIG) Sales in Volume for the Year 2017-2028
1.3 United States Human Hepatitis B Immunoglobulin(HBIG) Outlook 2017 VS 2022 VS 2028
1.3.1 United States Human Hepatitis B Immunoglobulin(HBIG) Sales in US$ Million for the Year 2017-2028
1.3.2 United States Human Hepatitis B Immunoglobulin(HBIG) Sales in Volume for the Year 2017-2028
1.4 Human Hepatitis B Immunoglobulin(HBIG) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Human Hepatitis B Immunoglobulin(HBIG) in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Human Hepatitis B Immunoglobulin(HBIG) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Human Hepatitis B Immunoglobulin(HBIG) Market Dynamics
1.5.1 Human Hepatitis B Immunoglobulin(HBIG) Industry Trends
1.5.2 Human Hepatitis B Immunoglobulin(HBIG) Market Drivers
1.5.3 Human Hepatitis B Immunoglobulin(HBIG) Market Challenges
1.5.4 Human Hepatitis B Immunoglobulin(HBIG) Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Human Hepatitis B Immunoglobulin(HBIG) Market Segment by Type
2.1.1 100IU/Bottle Human Hepatitis B Immunoglobulin
2.1.2 200IU/Bottle Human Hepatitis B Immunoglobulin
2.1.3 400IU/Bottle Human Hepatitis B Immunoglobulin
2.2 Global Human Hepatitis B Immunoglobulin(HBIG) Market Size by Type
2.2.1 Global Human Hepatitis B Immunoglobulin(HBIG) Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Human Hepatitis B Immunoglobulin(HBIG) Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Human Hepatitis B Immunoglobulin(HBIG) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Human Hepatitis B Immunoglobulin(HBIG) Market Size by Type
2.3.1 United States Human Hepatitis B Immunoglobulin(HBIG) Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Human Hepatitis B Immunoglobulin(HBIG) Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Human Hepatitis B Immunoglobulin(HBIG) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Human Hepatitis B Immunoglobulin(HBIG) Market Segment by Application
3.1.1 Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg)
3.1.2 Unexpected Crowd of Hepatitis B Infection
3.1.3 Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
3.2 Global Human Hepatitis B Immunoglobulin(HBIG) Market Size by Application
3.2.1 Global Human Hepatitis B Immunoglobulin(HBIG) Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Human Hepatitis B Immunoglobulin(HBIG) Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Human Hepatitis B Immunoglobulin(HBIG) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Human Hepatitis B Immunoglobulin(HBIG) Market Size by Application
3.3.1 United States Human Hepatitis B Immunoglobulin(HBIG) Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Human Hepatitis B Immunoglobulin(HBIG) Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Human Hepatitis B Immunoglobulin(HBIG) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Human Hepatitis B Immunoglobulin(HBIG) Competitor Landscape by Company
4.1 Global Human Hepatitis B Immunoglobulin(HBIG) Market Size by Company
4.1.1 Top Global Human Hepatitis B Immunoglobulin(HBIG) Manufacturers Ranked by Revenue (2021)
4.1.2 Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Manufacturer (2017-2022)
4.1.3 Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Manufacturer (2017-2022)
4.1.4 Global Human Hepatitis B Immunoglobulin(HBIG) Price by Manufacturer (2017-2022)
4.2 Global Human Hepatitis B Immunoglobulin(HBIG) Concentration Ratio (CR)
4.2.1 Human Hepatitis B Immunoglobulin(HBIG) Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Human Hepatitis B Immunoglobulin(HBIG) in 2021
4.2.3 Global Human Hepatitis B Immunoglobulin(HBIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Human Hepatitis B Immunoglobulin(HBIG) Manufacturing Base Distribution, Product Type
4.3.1 Global Human Hepatitis B Immunoglobulin(HBIG) Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Human Hepatitis B Immunoglobulin(HBIG) Product Type
4.3.3 Date of International Manufacturers Enter into Human Hepatitis B Immunoglobulin(HBIG) Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Human Hepatitis B Immunoglobulin(HBIG) Market Size by Company
4.5.1 Top Human Hepatitis B Immunoglobulin(HBIG) Players in United States, Ranked by Revenue (2021)
4.5.2 United States Human Hepatitis B Immunoglobulin(HBIG) Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Human Hepatitis B Immunoglobulin(HBIG) Sales by Players (2020, 2021 & 2022)
5 Global Human Hepatitis B Immunoglobulin(HBIG) Market Size by Region
5.1 Global Human Hepatitis B Immunoglobulin(HBIG) Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Human Hepatitis B Immunoglobulin(HBIG) Market Size in Volume by Region (2017-2028)
5.2.1 Global Human Hepatitis B Immunoglobulin(HBIG) Sales in Volume by Region: 2017-2022
5.2.2 Global Human Hepatitis B Immunoglobulin(HBIG) Sales in Volume Forecast by Region (2023-2028)
5.3 Global Human Hepatitis B Immunoglobulin(HBIG) Market Size in Value by Region (2017-2028)
5.3.1 Global Human Hepatitis B Immunoglobulin(HBIG) Sales in Value by Region: 2017-2022
5.3.2 Global Human Hepatitis B Immunoglobulin(HBIG) Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Human Hepatitis B Immunoglobulin(HBIG) Market Size YoY Growth 2017-2028
6.1.2 North America Human Hepatitis B Immunoglobulin(HBIG) Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Human Hepatitis B Immunoglobulin(HBIG) Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Human Hepatitis B Immunoglobulin(HBIG) Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Human Hepatitis B Immunoglobulin(HBIG) Market Size YoY Growth 2017-2028
6.3.2 Europe Human Hepatitis B Immunoglobulin(HBIG) Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Human Hepatitis B Immunoglobulin(HBIG) Market Size YoY Growth 2017-2028
6.4.2 Latin America Human Hepatitis B Immunoglobulin(HBIG) Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Baxter
7.1.1 Baxter Corporation Information
7.1.2 Baxter Description and Business Overview
7.1.3 Baxter Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Baxter Human Hepatitis B Immunoglobulin(HBIG) Products Offered
7.1.5 Baxter Recent Development
7.2 CSL
7.2.1 CSL Corporation Information
7.2.2 CSL Description and Business Overview
7.2.3 CSL Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue and Gross Margin (2017-2022)
7.2.4 CSL Human Hepatitis B Immunoglobulin(HBIG) Products Offered
7.2.5 CSL Recent Development
7.3 Bayer
7.3.1 Bayer Corporation Information
7.3.2 Bayer Description and Business Overview
7.3.3 Bayer Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Bayer Human Hepatitis B Immunoglobulin(HBIG) Products Offered
7.3.5 Bayer Recent Development
7.4 Grifols
7.4.1 Grifols Corporation Information
7.4.2 Grifols Description and Business Overview
7.4.3 Grifols Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Grifols Human Hepatitis B Immunoglobulin(HBIG) Products Offered
7.4.5 Grifols Recent Development
7.5 Octapharma
7.5.1 Octapharma Corporation Information
7.5.2 Octapharma Description and Business Overview
7.5.3 Octapharma Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Octapharma Human Hepatitis B Immunoglobulin(HBIG) Products Offered
7.5.5 Octapharma Recent Development
7.6 Shanghai RAAS
7.6.1 Shanghai RAAS Corporation Information
7.6.2 Shanghai RAAS Description and Business Overview
7.6.3 Shanghai RAAS Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Shanghai RAAS Human Hepatitis B Immunoglobulin(HBIG) Products Offered
7.6.5 Shanghai RAAS Recent Development
7.7 Hualan Biological
7.7.1 Hualan Biological Corporation Information
7.7.2 Hualan Biological Description and Business Overview
7.7.3 Hualan Biological Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Hualan Biological Human Hepatitis B Immunoglobulin(HBIG) Products Offered
7.7.5 Hualan Biological Recent Development
7.8 China Biologic
7.8.1 China Biologic Corporation Information
7.8.2 China Biologic Description and Business Overview
7.8.3 China Biologic Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue and Gross Margin (2017-2022)
7.8.4 China Biologic Human Hepatitis B Immunoglobulin(HBIG) Products Offered
7.8.5 China Biologic Recent Development
7.9 Tiantan Biologic
7.9.1 Tiantan Biologic Corporation Information
7.9.2 Tiantan Biologic Description and Business Overview
7.9.3 Tiantan Biologic Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Tiantan Biologic Human Hepatitis B Immunoglobulin(HBIG) Products Offered
7.9.5 Tiantan Biologic Recent Development
7.10 Shuanglin Bio-pharmacy
7.10.1 Shuanglin Bio-pharmacy Corporation Information
7.10.2 Shuanglin Bio-pharmacy Description and Business Overview
7.10.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin(HBIG) Products Offered
7.10.5 Shuanglin Bio-pharmacy Recent Development
7.11 Sichuan Yuanda Shuyang
7.11.1 Sichuan Yuanda Shuyang Corporation Information
7.11.2 Sichuan Yuanda Shuyang Description and Business Overview
7.11.3 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin(HBIG) Products Offered
7.11.5 Sichuan Yuanda Shuyang Recent Development
7.12 Boya Bio-pharmaceutical
7.12.1 Boya Bio-pharmaceutical Corporation Information
7.12.2 Boya Bio-pharmaceutical Description and Business Overview
7.12.3 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Boya Bio-pharmaceutical Products Offered
7.12.5 Boya Bio-pharmaceutical Recent Development
7.13 Shanghai Institute of Biological
7.13.1 Shanghai Institute of Biological Corporation Information
7.13.2 Shanghai Institute of Biological Description and Business Overview
7.13.3 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Shanghai Institute of Biological Products Offered
7.13.5 Shanghai Institute of Biological Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Human Hepatitis B Immunoglobulin(HBIG) Industry Chain Analysis
8.2 Human Hepatitis B Immunoglobulin(HBIG) Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Human Hepatitis B Immunoglobulin(HBIG) Distributors
8.3 Human Hepatitis B Immunoglobulin(HBIG) Production Mode & Process
8.4 Human Hepatitis B Immunoglobulin(HBIG) Sales and Marketing
8.4.1 Human Hepatitis B Immunoglobulin(HBIG) Sales Channels
8.4.2 Human Hepatitis B Immunoglobulin(HBIG) Distributors
8.5 Human Hepatitis B Immunoglobulin(HBIG) Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Human Hepatitis B Immunoglobulin(HBIG) CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Human Hepatitis B Immunoglobulin(HBIG) Market Trends
Table 3. Human Hepatitis B Immunoglobulin(HBIG) Market Drivers
Table 4. Human Hepatitis B Immunoglobulin(HBIG) Market Challenges
Table 5. Human Hepatitis B Immunoglobulin(HBIG) Market Restraints
Table 6. Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Human Hepatitis B Immunoglobulin(HBIG) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Human Hepatitis B Immunoglobulin(HBIG) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Human Hepatitis B Immunoglobulin(HBIG) Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Share by Manufacturer, 2017-2022
Table 13. Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Share by Manufacturer, 2017-2022
Table 15. Global Human Hepatitis B Immunoglobulin(HBIG) Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Human Hepatitis B Immunoglobulin(HBIG) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Human Hepatitis B Immunoglobulin(HBIG) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Hepatitis B Immunoglobulin(HBIG) as of 2021)
Table 18. Top Players of Human Hepatitis B Immunoglobulin(HBIG) in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Human Hepatitis B Immunoglobulin(HBIG) Product Type
Table 20. Date of International Manufacturers Enter into Human Hepatitis B Immunoglobulin(HBIG) Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Human Hepatitis B Immunoglobulin(HBIG) Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Human Hepatitis B Immunoglobulin(HBIG) Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Human Hepatitis B Immunoglobulin(HBIG) Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Human Hepatitis B Immunoglobulin(HBIG) Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Human Hepatitis B Immunoglobulin(HBIG) Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Human Hepatitis B Immunoglobulin(HBIG) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Human Hepatitis B Immunoglobulin(HBIG) Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Human Hepatitis B Immunoglobulin(HBIG) Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Human Hepatitis B Immunoglobulin(HBIG) Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Human Hepatitis B Immunoglobulin(HBIG) Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Human Hepatitis B Immunoglobulin(HBIG) Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Human Hepatitis B Immunoglobulin(HBIG) Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Human Hepatitis B Immunoglobulin(HBIG) Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Baxter Corporation Information
Table 43. Baxter Description and Business Overview
Table 44. Baxter Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Baxter Human Hepatitis B Immunoglobulin(HBIG) Product
Table 46. Baxter Recent Development
Table 47. CSL Corporation Information
Table 48. CSL Description and Business Overview
Table 49. CSL Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. CSL Product
Table 51. CSL Recent Development
Table 52. Bayer Corporation Information
Table 53. Bayer Description and Business Overview
Table 54. Bayer Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. Bayer Product
Table 56. Bayer Recent Development
Table 57. Grifols Corporation Information
Table 58. Grifols Description and Business Overview
Table 59. Grifols Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Grifols Product
Table 61. Grifols Recent Development
Table 62. Octapharma Corporation Information
Table 63. Octapharma Description and Business Overview
Table 64. Octapharma Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. Octapharma Product
Table 66. Octapharma Recent Development
Table 67. Shanghai RAAS Corporation Information
Table 68. Shanghai RAAS Description and Business Overview
Table 69. Shanghai RAAS Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. Shanghai RAAS Product
Table 71. Shanghai RAAS Recent Development
Table 72. Hualan Biological Corporation Information
Table 73. Hualan Biological Description and Business Overview
Table 74. Hualan Biological Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. Hualan Biological Product
Table 76. Hualan Biological Recent Development
Table 77. China Biologic Corporation Information
Table 78. China Biologic Description and Business Overview
Table 79. China Biologic Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. China Biologic Product
Table 81. China Biologic Recent Development
Table 82. Tiantan Biologic Corporation Information
Table 83. Tiantan Biologic Description and Business Overview
Table 84. Tiantan Biologic Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. Tiantan Biologic Product
Table 86. Tiantan Biologic Recent Development
Table 87. Shuanglin Bio-pharmacy Corporation Information
Table 88. Shuanglin Bio-pharmacy Description and Business Overview
Table 89. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. Shuanglin Bio-pharmacy Product
Table 91. Shuanglin Bio-pharmacy Recent Development
Table 92. Sichuan Yuanda Shuyang Corporation Information
Table 93. Sichuan Yuanda Shuyang Description and Business Overview
Table 94. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 95. Sichuan Yuanda Shuyang Product
Table 96. Sichuan Yuanda Shuyang Recent Development
Table 97. Boya Bio-pharmaceutical Corporation Information
Table 98. Boya Bio-pharmaceutical Description and Business Overview
Table 99. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 100. Boya Bio-pharmaceutical Product
Table 101. Boya Bio-pharmaceutical Recent Development
Table 102. Shanghai Institute of Biological Corporation Information
Table 103. Shanghai Institute of Biological Description and Business Overview
Table 104. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 105. Shanghai Institute of Biological Product
Table 106. Shanghai Institute of Biological Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Human Hepatitis B Immunoglobulin(HBIG) Customers List
Table 110. Human Hepatitis B Immunoglobulin(HBIG) Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Hepatitis B Immunoglobulin(HBIG) Product Picture
Figure 2. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Human Hepatitis B Immunoglobulin(HBIG) Market Size 2017-2028 (US$ Million)
Figure 4. Global Human Hepatitis B Immunoglobulin(HBIG) Sales 2017-2028 (K Pcs)
Figure 5. United States Human Hepatitis B Immunoglobulin(HBIG) Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Human Hepatitis B Immunoglobulin(HBIG) Market Size 2017-2028 (US$ Million)
Figure 7. United States Human Hepatitis B Immunoglobulin(HBIG) Sales 2017-2028 (K Pcs)
Figure 8. United States Human Hepatitis B Immunoglobulin(HBIG) Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Human Hepatitis B Immunoglobulin(HBIG) Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Human Hepatitis B Immunoglobulin(HBIG) Report Years Considered
Figure 11. Product Picture of 100IU/Bottle Human Hepatitis B Immunoglobulin
Figure 12. Product Picture of 200IU/Bottle Human Hepatitis B Immunoglobulin
Figure 13. Product Picture of 400IU/Bottle Human Hepatitis B Immunoglobulin
Figure 14. Global Human Hepatitis B Immunoglobulin(HBIG) Market Share by Type in 2022 & 2028
Figure 15. Global Human Hepatitis B Immunoglobulin(HBIG) Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2017-2028) & (K Pcs)
Figure 18. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Human Hepatitis B Immunoglobulin(HBIG) Price by Type (2017-2028) & (USD/Pcs)
Figure 20. United States Human Hepatitis B Immunoglobulin(HBIG) Market Share by Type in 2022 & 2028
Figure 21. United States Human Hepatitis B Immunoglobulin(HBIG) Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2017-2028) & (K Pcs)
Figure 24. United States Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Human Hepatitis B Immunoglobulin(HBIG) Price by Type (2017-2028) & (USD/Pcs)
Figure 26. Product Picture of Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg)
Figure 27. Product Picture of Unexpected Crowd of Hepatitis B Infection
Figure 28. Product Picture of Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
Figure 29. Global Human Hepatitis B Immunoglobulin(HBIG) Market Share by Application in 2022 & 2028
Figure 30. Global Human Hepatitis B Immunoglobulin(HBIG) Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2017-2028) & (K Pcs)
Figure 33. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Human Hepatitis B Immunoglobulin(HBIG) Price by Application (2017-2028) & (USD/Pcs)
Figure 35. United States Human Hepatitis B Immunoglobulin(HBIG) Market Share by Application in 2022 & 2028
Figure 36. United States Human Hepatitis B Immunoglobulin(HBIG) Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2017-2028) & (K Pcs)
Figure 39. United States Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Human Hepatitis B Immunoglobulin(HBIG) Price by Application (2017-2028) & (USD/Pcs)
Figure 41. North America Human Hepatitis B Immunoglobulin(HBIG) Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 42. North America Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 46. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Human Hepatitis B Immunoglobulin(HBIG) Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 53. Asia-Pacific Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Human Hepatitis B Immunoglobulin(HBIG) Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 65. Latin America Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 70. Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. U.A.E Human Hepatitis B Immunoglobulin(HBIG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Human Hepatitis B Immunoglobulin(HBIG) Value Chain
Figure 75. Human Hepatitis B Immunoglobulin(HBIG) Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Baxter CSL Bayer Grifols Octapharma Shanghai RAAS Hualan Biological China Biologic Tiantan Biologic Shuanglin Bio-pharmacy Sichuan Yuanda Shuyang Boya Bio-pharmaceutical Shanghai Institute of Biological